Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The update aims to help the public better protect themselves and understand their risk.
Antibody levels decrease substantially within three months after a booster, according to new clinical trial data.
Vaccines designed to produce a strong T cell response may help protect against current and future SARS-CoV-2 variants.
The nation’s top pandemic adviser joins a growing number of people catching the coronavirus during the omicron wave.
The good news is that only 4% of HIV-positive people experienced COVID breakthrough after vaccination.
Approximately 1 in 3 Americans 65 and older who completed their initial vaccination round still have not received a first booster shot.
National Comprehensive Cancer Network encourages second mRNA booster shot and offers COVID PrEP advice for people with cancer.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
The quick spread of the BA.2 subvariant is likely due to its greater infectiousness rather than its ability to evade the immune system.
NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.
The benefits of achieving herd immunity thresholds have been less successful with respiratory viruses that continually mutate.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.
The CDC’s move triggered mixed feelings from the public and laid bare a split within the health care community.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.